Clinical Trials

Showing trials with last updates posted in 2023.

NCT06048315 | NOT_YET_RECRUITING | PHASE3
52 participants

A Single Center, Single Arm Clinical Study on the Treatment of Advanced Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations and Failed EGFR TKIs With the Combination of Enrotinib and Paclitaxel Monoclonal Antibody

Study Type:
INTERVENTIONAL
Last Updated:
2023-09-21
Start Date:
2023-09-30
Completion:
2026-06-30
Conditions
  • Lung Cancer
  • TKI Resistance
  • EGFR Sensitive Mutation
  • Anlotinib
  • Pianzumab
Interventions
  • DRUG
No Results Yet
NCT06048224 | COMPLETED | PHASE3
669 participants

Phase III Clinical Trial Comparing the Safety, Efficacy, and Immunogenicity of Recombinant Anti-interleukin-6 Receptor Humanized Monoclonal Antibody Injection in Combination With Methotrexate and Jamelor ® in the Treatment of Moderate to Severe Rheumatoid Arthritis

Study Type:
INTERVENTIONAL
Last Updated:
2023-09-21
Start Date:
2020-12-28
Completion:
2021-09-14
Conditions
  • Moderate to Severe Active Rheumatoid Arthritis
Interventions
  • DRUG
No Results Yet
NCT06047158 | UNKNOWN
200 participants

Effects of Omega-3 Fish Oil Fat Emulsion on Rehabilitation and Immune Function After Radical Surgery Combined With Intraperitoneal Hyperthermic Infusion Chemotherapy in Patients With Locally Advanced Gastric Cancer

Study Type:
OBSERVATIONAL
Last Updated:
2023-09-21
Start Date:
2022-12-01
Completion:
2023-12-01
Conditions
  • Fish Oils
  • Perfusion; Complications
  • Stomach Neoplasms
  • Nutrition Aspect of Cancer
  • Chemotherapy Effect
  • Immunisation Reaction
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page